These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3323599)

  • 1. The enhancement of aminonucleoside nephrosis by the co-administration of protamine.
    Saito T; Sumithran E; Glasgow EF; Atkins RC
    Kidney Int; 1987 Nov; 32(5):691-9. PubMed ID: 3323599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.
    Glasser RJ; Velosa JA; Michael AF
    Lab Invest; 1977 May; 36(5):519-26. PubMed ID: 865079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside.
    Diamond JR; Karnovsky MJ
    Am J Pathol; 1986 Mar; 122(3):481-7. PubMed ID: 3953770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent nephrotic syndrome and focal glomerular sclerosis produced in rats by aminonucleoside and protamine.
    Saito T; Yamakage K; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1982 Sep; 138(1):117-8. PubMed ID: 7147231
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study on correlation between aminonucleoside induced experimental focal glomerular sclerosis and mesangial dysfunction in rats (author's transl)].
    Sawaguchi H
    Nihon Jinzo Gakkai Shi; 1982 Feb; 24(2):109-24. PubMed ID: 7098139
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesangial function and glomerular sclerosis in rats with aminonucleoside nephrosis.
    Grond J; Koudstaal J; Elema JD
    Kidney Int; 1985 Feb; 27(2):405-10. PubMed ID: 3990093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
    Saito T; Yamakage K; Kurosawa K; Kyogoku Y; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1982 Apr; 136(4):461-2. PubMed ID: 7101279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of protamine on serum complement activity in aminonucleoside nephropathy.
    Fukuda K; Seino J; Saito T; Yamakage K; Kyogoku Y; Kurosawa K; Sato H; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1984 Jul; 143(3):315-8. PubMed ID: 6484978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of experimental focal glomerulosclerosis in the spontaneously hypertensive rat.
    Saito T; Sato H; Obara K; Yamakage K; Abe K; Furuyama T; Yoshinaga K
    J Lab Clin Med; 1990 Feb; 115(2):165-73. PubMed ID: 2299264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal glomerular sclerosis in aminonucleoside nephropathy.
    Saito T; Furuyama T; Kyogoku Y; Yamakage K; Arakawa M; Yoshinaga K
    Tohoku J Exp Med; 1981 Mar; 133(3):349-60. PubMed ID: 6171910
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences in puromycin aminonucleoside nephrosis in two rat strains.
    Grond J; Muller EW; van Goor H; Weening JJ; Elema JD
    Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.
    Diamond JR; Karnovsky MJ
    Kidney Int; 1987 Nov; 32(5):671-7. PubMed ID: 3430956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
    Diamond JR; Karnovsky MJ
    J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal glomerular hyalinosis and sclerosis in aminonucleoside and adriamycin nephrosis: pathogenetic and therapeutic considerations.
    Elema JD; Weening JJ; Grond J
    Contrib Nephrol; 1988; 60():73-82. PubMed ID: 3278860
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis.
    Hagiwara M; Yamagata K; Capaldi RA; Koyama A
    Kidney Int; 2006 Apr; 69(7):1146-52. PubMed ID: 16609681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow-up study of glomerular lesions in aminonucleoside nephrosis].
    Hirabayashi K; Ishitobi F; Takimoto T; Kure N; Iidaka K
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):387-400. PubMed ID: 3747250
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a low-protein diet on glomerular endothelin family gene expression in experimental focal glomerular sclerosis.
    Nakamura T; Fukui M; Ebihara I; Osada S; Takahashi T; Tomino Y; Koide H
    Clin Sci (Lond); 1995 Jan; 88(1):29-37. PubMed ID: 7704997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of benidipine against the development of glomerular sclerosis in experimental nephrotic syndrome.
    Shirakura S; Sano J; Karasawa A; Kubo K
    Jpn J Pharmacol; 1992 Aug; 59(4):461-7. PubMed ID: 1434141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.